OTC · HSTC
HST Global, Inc.
$0.70$0.00 (0.0%)
HST Global, Inc.’s quoted price sits in the upper half of its reported 52-week range, 33.33% below the high.
Loading market information…
OTC · KKUR · USD
Stock price
Quote as of Oct 26, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
ChromoCure, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
ChromoCure, Inc. specializes in designing and delivering exclusive systems for cancer identification. Their primary offering, the Chromosomal Scanner Series 200, is a detection system capable of identifying a distinct genomic characteristic that is universally present in all cancers yet entirely absent in healthy cells. Furthermore, the company dedicates its scientific and technological expertise to investigating non-toxic and non-invasive strategies for both cancer treatment and cure research. Established in 2001 and based in Reno, Nevada, the organization rebranded as ChromoCure, Inc. in June 2009, having previously been known as Cyberhand Technologies International, Inc.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:19 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$0.70$0.00 (0.0%)
HST Global, Inc.’s quoted price sits in the upper half of its reported 52-week range, 33.33% below the high.
€0.71-€0.03 (-4.59%)
Theraclion S.A.’s quoted price sits in the upper half of its reported 52-week range, 24.09% below the high.
$0.00$0.00 (0.0%)
Biostax Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Medite Cancer Diagnostics, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Ceres Ventures, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00$0.00 (0.0%)
Neurogenesis, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
GSRX Industries Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00$0.00 (0.0%)
Accelera Innovations, Inc: Healthcare · Medical - Healthcare Information Services.
